Researchers conducted a retrospective cohort study of patients undergoing TAVR at 229 U.S. sites between November 2011 and September 2014. They used the Society of Thoracic Surgeons/American College of Cardiology TVT Registry and the CMS database.
Here are four findings:
1. Permanent pacemaker placement was required within 30 days of TAVR in 651 of the 9,785 patients (6.7 percent).
2. Age, prior conduction defect and use of self-expanding valve were positive predictors of pacemaker implantation.
3. Permanent pacemaker implantation was associated with a seven-day median hospital stay and 56.7-hour intensive care unit stay.
4. Permanent pacemaker implantation was also associated with a 24.1 percent mortality rate.
More articles on healthcare quality:
ECRI names 10 health technology hazards for 2017 — infusion errors, scope cleaning top list
HHS report identifies 7 new cancer-causing substances
AFM ruled out in death of Seattle Children’s patient, confirmed in 8 others
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
